Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for AVITA Medical (RCEL) over the last 8 years, with Q3 2025 value amounting to $28.4 million.

  • AVITA Medical's Shares Outstanding (Diluted Average) rose 927.28% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 927.28%. This contributed to the annual value of $25.3 million for FY2023, which is 132.43% up from last year.
  • Latest data reveals that AVITA Medical reported Shares Outstanding (Diluted Average) of $28.4 million as of Q3 2025, which was up 927.28% from $26.4 million recorded in Q2 2025.
  • Over the past 5 years, AVITA Medical's Shares Outstanding (Diluted Average) peaked at $28.4 million during Q3 2025, and registered a low of $22.7 million during Q2 2021.
  • For the 5-year period, AVITA Medical's Shares Outstanding (Diluted Average) averaged around $25.3 million, with its median value being $25.2 million (2023).
  • As far as peak fluctuations go, AVITA Medical's Shares Outstanding (Diluted Average) skyrocketed by 1581.75% in 2021, and later skyrocketed by 34.02% in 2022.
  • AVITA Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $24.9 million in 2021, then increased by 0.34% to $25.0 million in 2022, then grew by 1.32% to $25.3 million in 2023, then increased by 2.58% to $26.0 million in 2024, then grew by 9.27% to $28.4 million in 2025.
  • Its last three reported values are $28.4 million in Q3 2025, $26.4 million for Q2 2025, and $26.3 million during Q1 2025.